Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ACACB | O00763 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 6/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 6/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.37 |
| ▸ | HDAC10 | Q969S8 | 5/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.36 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.36 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.36 |
| ▸ | TRHR | P34981 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27758974 | 1.00 | POLB (0.43) | POLBSMN1; SMN2MEN1KMT2AACACB | |
| SCHEMBL29511483 | 1.00 | POLB (0.43) | POLBSMN1; SMN2MEN1KMT2AACACB | |
| SCHEMBL27758972 | 1.00 | POLB (0.43) | POLBSMN1; SMN2MEN1KMT2AACACB | |
| SCHEMBL31199165 | 0.87 | POLB (0.38) | POLBSMN1; SMN2MEN1KMT2AACACB | |
| SCHEMBL18818408 | 0.86 | POLB (0.42) | POLBSMN1; SMN2MEN1KMT2AACACB | |
| SCHEMBL11738722 | 0.86 | POLB (0.42) | POLBSMN1; SMN2MEN1KMT2AACACB | |
| SCHEMBL25039712 | 0.85 | POLB (0.46) | POLBSMN1; SMN2MEN1KMT2AACACB | |
| SCHEMBL2597779 | 0.84 | SMN1; SMN2 (0.42) | POLBSMN1; SMN2MEN1KMT2AACACB | |
| SCHEMBL2597780 | 0.84 | SMN1; SMN2 (0.42) | POLBSMN1; SMN2MEN1KMT2AACACB | |
| SCHEMBL20560032 | 0.84 | SMN1; SMN2 (0.42) | POLBSMN1; SMN2MEN1KMT2AACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120084911-A | Method for measuring alanyl glutamine related substances | 苏州科伦药物研究有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-113933403-B | Method for measuring alanyl glutamine related substances | 苏州科伦药物研究有限公司 | 2025-04-25 | — | — | CN | claimed |
| EP-4196608-B1 | NUCLEOSIDE-5'-OLIGOPHOSPHATES TAGGED WITH POSITIVELY-CHARGED POLYMERS, NANOPORES INCORPORATING NEGATIVE CHARGES, AND METHODS AND SYSTEMS USING THE SAME | HOFFMANN LA ROCHE (CH) | 2024-10-23 | — | — | EP | claimed |
| US-20240150824-A1 | NUCLEOSIDE-5'-OLIGOPHOSPHATES TAGGED WITH POSTIVIELY-CHARGED POLYMERS, NANOPORES INCORPORATING NEGATIVE CHARGES, AND METHODS AND SYSTEMS USING THE SAME | ROCHE SEQUENCING SOLUTIONS INC (US) | 2024-05-09 | — | — | US | claimed |
| EP-4196608-A1 | NUCLEOSIDE-5'-OLIGOPHOSPHATES TAGGED WITH POSITIVELY-CHARGED POLYMERS, NANOPORES INCORPORATING NEGATIVE CHARGES, AND METHODS AND SYSTEMS USING THE SAME | F. Hoffmann-La Roche AG (CH) | 2023-06-21 | — | — | EP | claimed |
| CN-115932113-A | Method for detecting impurities in alanyl-glutamine-containing compound amino acid pharmaceutical composition | 远大生命科学(武汉)有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-111812259-B | Method for detecting alanyl glutamine impurity in compound amino acid injection | 费森尤斯卡比华瑞制药有限公司 | 2022-11-04 | — | — | CN | claimed |
| CN-111812259-A | Method for detecting alanyl glutamine impurity in compound amino acid injection | 费森尤斯卡比华瑞制药有限公司 | 2020-10-23 | — | — | CN | claimed |
| CN-106806884-B | N (2) -L-alanyl-L-glutamine injection and preparation method thereof | 武汉大安制药有限公司 | 2020-06-19 | — | — | CN | claimed |
| US-6872539-B2 | Analytical system based upon spore germination | ROTMAN M BORIS (US) | 2005-03-29 | — | — | US | claimed |
| US-20030008337-A1 | Analytical system based upon spore germination | ROTMAN M BORIS (US) | 2003-01-09 | — | — | US | claimed |
| US-6228574-B1 | RAPID DETECTION BY MIXING TEST SAMPLE WITH MICROBIAL SPORES AND GERMINOGENIC SOURCE, INCUBATING TO ALLOW ACTIVATION OF SPORES AND ENZYMATIC CONVERSION OF SOURCE TO A GERMINANT AND FOR SPORE GERMINATION, THEN DETECTING GERMINATION | ROTMAN M BORIS (US) | 2001-05-08 | — | — | US | claimed |
| US-20250325683-A1 | LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE | SCRIPPS RESEARCH INST (US) | 2025-10-23 | — | — | US | disclosed |
| US-20250320252-A1 | LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE | SCRIPPS RESEARCH INST (US) | 2025-10-16 | — | — | US | disclosed |
| US-20250268291-A1 | FLAVOR COMPOSITIONS AND SCREENING METHODS FOR IDENTIFYING THE SAME | MARS, INCORPORATED (US) | 2025-08-28 | — | — | US | disclosed |
| US-12329823-B2 | Long-acting dual GIP/GLP-1 peptide conjugates and methods of use | THE SCRIPPS RESEARCH INSTITUTE (US) | 2025-06-17 | — | — | US | disclosed |
| US-20030008337-A1 | Analytical system based upon spore germination | ROTMAN M BORIS (US) | 2003-01-09 | — | — | US | disclosed |
| EP-1131462-A1 | ANALYTICAL SYSTEM BASED UPON SPORE GERMINATION | Rotman, M. Boris (US) | 2001-09-12 | — | — | EP | disclosed |
| US-6228574-B1 | RAPID DETECTION BY MIXING TEST SAMPLE WITH MICROBIAL SPORES AND GERMINOGENIC SOURCE, INCUBATING TO ALLOW ACTIVATION OF SPORES AND ENZYMATIC CONVERSION OF SOURCE TO A GERMINANT AND FOR SPORE GERMINATION, THEN DETECTING GERMINATION | ROTMAN M BORIS (US) | 2001-05-08 | — | — | US | disclosed |
| WO-2000029610-A1 | ANALYTICAL SYSTEM BASED UPON SPORE GERMINATION | ROTMAN M BORIS (US) | 2000-05-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325683-A1 | LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE | GLP1R, GIPR, GCGR | POLB 4817/4885SMN1; SMN2 2659/4885MEN1 1457/4885 |
| US-12329823-B2 | Long-acting dual GIP/GLP-1 peptide conjugates and methods of use | GLP1R, GIPR, GCGR | POLB 4817/4885SMN1; SMN2 2659/4885MEN1 1457/4885 |
| US-20250320252-A1 | LONG-ACTING DUAL GIP/GLP-1 PEPTIDE CONJUGATES AND METHODS OF USE | GLP1R, GIPR, GCGR | POLB 4817/4885SMN1; SMN2 2659/4885MEN1 1457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.